Ca2+-independent cytosolic phospholipase A in HL-60 cells differentiating to granulocytes  by Hullin-Matsuda, Françoise et al.
FEBS 19593 FEBS Letters 419 (1997) 117-120 
Ca2+-independent cytosolic phospholipase A in HL-60 cells 
differentiating to granulocytes 
Francoise Hullin-Matsuda1, Yosuke Tsujishita, Yasutomi Nishizuka* 
Biosignal Research Center, Kobe University, Kobe 657, Japan 
Received 4 November 1997 
Abstract The release of various fatty acids (FAs) from 
permeabilized HL-60 cells, predominantly oleic acid (OA) rather 
than arachidonic acid, was greatly enhanced by GTP-y-S and 
vanadate [Tsujishita, Y., Asaoka, Y. and Nishizuka, Y., Proc. 
Nati. Acad. Sci. USA 91 (1994) 6274-6278|. The present study 
shows that phospholipase A (A2/Ai) activity which cleaves the 
acyl group from both sn-2 and sn-l positions of phosphatidyl-
ethanolamine (PtdEtn) is increased in HL-60 cells during 
differentiation to granulocyte-like cells. This enzyme does not 
require Ca2 + and releases various FAs, preferentially OA from 
PtdEtn and, to lesser extent, from lysoPtdEtn. Other phospho-
lipids including phosphatidylcholine and phosphatidic acid serve 
as very poor substrates. Although further studies are necessary to 
show the direct link of this enzyme activation to receptor 
stimulation, the results described here imply that this enzyme is 
responsible for the release of various FAs, particularly О A, from 
permeabilized HL-60 cells. 
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1. Introduction 
Several metabolites derived from signal-induced hydrolysis 
of membrane lipid components serve as messengers or medi-
ators to regulate intracellular events (for reviews, see [1-3]). 
Although unsaturated fatty acids (FAs) have been shown to 
exert various biological actions, such as modulat ion of ion 
channel properties, membrane fusion, long-term potentiation, 
and activation of protein kinases [3,4], little attention has been 
paid to FAs other than arachidonic acid (AA). After cell 
stimulation, FAs may be produced from membrane phospho-
lipids through several pathways initiated by activation of 
phospholipases С (PLC), D (PLD), and A2 /Ai (PLA 2 /Ai) . 
PLA2 is a large family of enzymes. The best characterized 
cytosolic PLA 2 is group IV 85 k D a (cPLA2) , which is linked 
to receptor stimulation through protein phosphorylation (for 
reviews, see [5,6]). This enzyme preferentially releases A A and 
requires Ca 2 + for its association with membranes. Group VII 
45 k D a (secreted) and group VIII 29 k D a (cytosolic) enzymes 
are platelet activating factor acetylhydrolases (for reviews, see 
[5,7]). More recently, group VI 80-85 k D a enzymes (iPLA2) 
were cloned and sequenced from C H O cells and mouse 
P388D] macrophages, which cleave various FAs non-selec-
tively from phosphatidic acid (PtdOH) and phosphatidylcho-
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line (PtdCho), and, to lesser extents, from phosphatidyletha-
nolamine (PtdEtn) and other phospholipids [8,9]. These 
enzymes are postulated to play a role in remodeling of mem-
brane phospholipids (for reviews, see [5,10]). 
In our early studies with permeabilized HL-60 and U-937 
cells, various FAs, predominantly oleic acid (OA) rather than 
AA, were released spontaneously. This release reaction was 
enhanced greatly by GTP-y-S and vanadate, and this enhance-
ment was attenuated by tyrosine kinase inhibitor [11]. How-
ever, no evidence is available to date indicating that the AA-
non-selective type of cytosolic PLA 2 (or PLAi) is directly 
linked to receptor stimulation. To explore the mechanism re-
sponsible for the release reaction of FAs, especially OA, from 
permeabilized cell preparations, the present studies were 
undertaken. 
2. Materials and methods 
2.1. Chemicals 
Leupeptin was obtained from Peptide Institute (Osaka). Dioleoyl-
PtdEtn, dioleoyl-PtdCho and (p-amidinophenyl)methanesulfonyl fluo-
ride hydrochloride (p-APMSF) were from Wako (Osaka). 1,2-Diolein 
was a product of Doosan Serdary (Englewood Cliffs, NJ). Other 
phospholipids and lysophospholipids, FAs, FA-free bovine serum al-
bumin were products of Sigma. 9-Anthryldiazomethane (ADAM) was 
purchased from Funakoshi (Tokyo), dissolved in acetone at a concen-
tration of 2.5% (w/v), and stored at —20°C in the dark. 1,2-Dioleoyl-
phosphatidyl[2-14C]ethanolamine (54 mCi/mmol) and 1-palmitoyl-2-
[l-14C]linoleoyl-PtdEtn (57 mCi/mmol) were products of Amersham. 
Arachidonyl trifluoromethyl ketone (AACOF3) and bromoenol lac-
tone (BEL; (iT)-6-(bromomethylene)-tetrahydro-3-(l-naphthalenyl)-
2ff-pyran-2-one) were from Calbiochem. Rabbit polyclonal antibody 
against the N-terminal domain (N-216) of human CPLA2 was ob-
tained from Santa Cruz Biotechnology (Santa Cruz, CA). 
2.2. Culture and differentiation of HL-60 
HL-60 cells were maintained as described [11]. When required, the 
cells were plated at 4.0 X 105 cells/ml, and treated with 1.25% dimethyl 
sulfoxide (DMSO) for various periods to differentiate to granulocyte-
like cells. The degree of differentiation was examined by the expres-
sion of a cell surface marker, CDl lb [12]. The granulocytic differ-
entiation was also assayed by the release of ß-glucuronidase [13]. 
When cultured with 1.25% DMSO, HL-60 cells displayed a progres-
sive decrease of their cytosolic protein as well as their total phospho-
lipid content as reported [14,15]. Both expression of CDl lb and re-
lease of ß-glucuronidase showed maximal values at 5 days after the 
addition of DMSO. Electro-permeabilized cells were prepared as de-
scribed [11]. 
2.3. Preparation of cytosol 
HL-60 cells were collected and washed in phosphate-buffered saline. 
All subsequent steps were performed at 4°C. The cells were suspended 
at a density of 0.5 or 1.0X 108 cells/ml for undifferentiated or 3-day 
differentiated HL-60 cells, respectively, in a buffer containing 25 mM 
Tris-HCl at pH 8.0, 2 mM EDTA, 250 mM sucrose, 50 μΜ 
/7-APMSF, and 20 μg/ml leupeptin. The cells were then disrupted by 
sonication. The cytosol was obtained by centrifugation for 30 min at 
lOOOOOXg. 
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2.4. MonoQ column chromatography 
The salt concentration of cytosol was adjusted to 250 mM NaCl 
before filtration through a Millipore filter (pore size 0.45 μpiι). Then, it 
was loaded onto a MonoQ HR5/5 column (0.5 cmX5 cm) pre-equi-
librated with a buffer containing 25 mM Tris-HCl at pH 8.0, 2 mM 
EDTA, 2 mM 2-mercaptoethanol and 250 mM NaCl (buffer A). After 
extensive washing with buffer A, elution was made with a 20-ml linear 
concentration gradient of NaCl (250-600 mM) in buffer A at a flow 
rate of 0.5 ml/min. Fractions (0.5 ml each) were collected. 
2.5. Endogenous lipid substrate 
Undifferentiated HL-60 cells were washed, suspended in phosphate-
buffered saline, sonicated for 1 min, and centrifuged for 10 min at 
1000 Xg. Then, the supernatant was centrifuged for an additional 
30 min at 100000Xg. The pellet was extracted with chloroform-meth-
anol (2:1, v/v) by the modified procedure of Bligh and Dyer [16] 
including acidification with HC1. The lipid mixture was dried, 
weighed, and suspended at 50 mg/ml (w/v) in chloroform-methanol. 
This endogenous lipid mixture (ELM) was used as a substrate for 
lipase assay. 
2.6. PL A assay 
For non-radioactive assay, the reaction mixture (250 μΐ) contained 
20 μΜ chemically defined phospholipid or 300 μ^piύ ELM, 20 mM 
Tris-HCl at pH 8.0, 2 mM EDTA, 8 mM MgCl2, 0.4 mg/ml of bovine 
serum albumin, 20% glycerol, and enzyme. The lipid vesicles were 
prepared by sonication on ice for 2 min in the assay buffer. After 
incubation for 30 min at 37°C, the reaction was terminated by adding 
1.25 ml of Dole reagent [17]. 
For radioactive assay, the phospholipid substrate was evaporated 
under N2, sonicated, and added to the reaction mixture at a final 
concentration of 20 μΜ. After incubation for 30 min at 37°C, lipids 
were extracted by the method of Bligh and Dyer [16]. 
2.7. FA and phospholipid determinations 
Non-radioactive FAs were determined with an HPLC system using 
ADAM as described [11] except that FAs were separated on an Octyl 
80-Ts column (4.6 mm X 250 mm, Tosoh, Tokyo). 
Radioactive lipids were separated by TLC on a Merck silica gel 60 
plate with chloroform/methanol/water, 65/25/4 (v/v/v) as a solvent 
[18]. Radioactivity of each lipid was determined with a BAS-2000 
Bioimage analyzer (Fuji, Tokyo). 
2.8. Other procedures 
Protein was determined by the method of Bradford [19] using bo-
vine serum albumin as a standard. Immunoblot analysis of cPLA2 
was made as described [20]. 
Fig. 1. Two major fractions for fatty acid release from endogenous 
lipid mixture (ELM). Cytosolic supernatant was prepared from (A) 
undifferentiated or (B) 3-day differentiated HL-60 cells, fractionated 
by MonoQ HR5/5 chromatography (pH 8.0 at 4°C). Fractions 
(0.5 ml each) obtained were assayed with ELM as substrate for the 
release of OA (open symbols) and AA (closed symbols). 
spontaneously, and this reaction was significantly enhanced 
by the addition of GTP-y-S, A T P and vanadate at p H 8.4 
as described [11] (Table 1). The release of О A far exceeded 
that of AA, and some saturated FAs were also released. When 
the cells were disrupted, the F A release from endogenous 
lipids became more predominant , but GTP-y-S, A T P and van-
adate showed no effect. The cytosol per se was inert, but could 
release FAs from E L M , suggesting the existence of enzyme(s) 
responsible for this F A release reaction in the cytosol. 
3.2. Two major fractions for fatty acid release 
The cytosol from differentiated cells released more OA from 
E L M than the cytosol from undifferentiated cells. Both cyto-
sols were separately subjected to M o n o Q column chromatog-
raphy, and assayed for the ability to release FAs from E L M 
(Fig. 1) and from structurally defined phospholipids as sub-
strates (Fig. 2). The results indicate that the cytosol contained 
apparently two major fractions, peak I and peak II, which 
were able to release FAs from phospholipids. Peak I released 
AA as well as OA, and did not appear to show much differ-
ence in its specific activity between the differentiated and non-
differentiated cells. On the other hand, peak II released pre-
dominantly OA rather than AA, and increased its specific 
activity during cell differentiation. 
3. Results 
3.1. Release of fatty acids 
Electro-permeabilized HL-60 cells released various FAs 
Table 1 
Release of various fatty acids from endogenous lipids 
Activator 
Palmitic acid 
Stearic acid 
Oleic acid 
Linoleic acid 
Linolenic acid 
Arachidonic acid 
Fatty acids released (pmol/min/107 cells) 
Permeabilized cells 
-
11.4 
8.9 
37.3 
5.2 
4.7 
8.5 
+ 
63.1 
36.1 
143.9 
20.7 
15.7 
38.3 
Cell-free 
-
103.8 
74.3 
137.4 
24.7 
22.0 
58.7 
system 
+ 
78.3 
66.8 
118.6 
18.7 
15.5 
48.2 
HL-60 cells were electro-permeabilized as described [11] in the pres-
ence of 1 mM CaCl2 and 1 mM EGTA at pH 8.4 with or without 
activator (250 μΜ ATP, 25 μΜ GTP-y-S, and 100 μΜ vanadate), and 
incubated at 37°C for 60 min. For cell-free system, cells were sus-
pended in the same buffer, sonicated for 1 min, and incubated with 
or without activator at 37°C for 20 min. The FAs released were 
extracted and determined as described. 
3.3. Peak I contains сРЬАц 
Peak I contained the well-defined enzyme, CPLA2, since this 
fraction preferentially cleaved A A from l-stearoyl-2-arachido-
noyl-PtdCho (Fig. 2), and its reaction required a millimolar 
order of Ca 2 + concentrations to reveal its maximal activity. 
Fig. 2. Two major fractions for fatty acid release from chemically 
defined phospholipid. Cytosolic supernatant was prepared from (A) 
undifferentiated or (B) 3-day differentiated HL-60 cells, fractionated 
by MonoQ HR5/5 chromatography (pH 8.0 at 4°C). Fractions 
(0.5 ml each) obtained were assayed for the release of OA (open 
symbols) and AA (closed symbols) with 20 μΜ dioleoyl-PtdEtn or 
20 μΜ l-stearoyl-2-arachidonoyl-PtdCho as substrate, respectively. 
2 mM CaCl2 was added when assayed with the latter substrate. 
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Table 2 
Characterization of the 
Substrate 
phospholipase A activity of peak II with radiolabeled substrates 
l,2-Dioleoyl-Ptd[14C] PtdEtn 
LysoPtdEtn 
l-Palmitoyl-2-
LysoPtdEtn 
[14C]linoleoyl-■PtdEtn 
Linoleic acid 
Control 
Peak II 
0.33 
2.32 
0.12 
0.76 
0.02 
1.49 
The PLA activity of partially purified peak II was determined in the absence of Ca2+ (with 2 mM EDTA). The reaction was carried out as 
described in Section 2. The control incubation was made without enzyme fraction. After incubation for 30 min, lipids were extracted and separated 
by TLC. The radioactivity corresponding to lysophosphohpids and free FA was determined. Results are expressed as percentage of the total 
radioactivity in each assay. 
Also, peak I fraction reacted with anti-cPLA2 antibody in 
immunoblot analysis. This peak I enzyme was inhibited by 
AACOF3, a cPLA2 inhibitor, but not by BEL, an iPLA2 
inhibitor [10]. 
3.4. Peak II contains 1PLA2 
To characterize the FA release reaction in peak II, an en-
zyme responsible for the production of OA was purified par-
tially with dioleoyl-PtdEtn as substrate over 1200-fold from 
the cytosol of differentiated cells by sequential column chro-
matographies on TSK SuperQ-5PW, TSK Phenyl-5PW, and 
TSK heparin-5PW. The overall yield was approximately 5% 
starting from the crude cytosol. 
With chemically defined radioactive PtdEtn as substrate, 
the enzyme preparation was shown to cleave FA at position 
2 as well as FA at position 1 (Table 2). In addition to this 
PLA2/A1 activity, the enzyme preparation also showed a weak 
lysophospholipase activity (Table 3). The activity to release 
FAs in this peak II fraction was insensitive to Ca2+, and 
was not affected by the addition of EGTA. 
3.5. Lipid specificity 
The enzyme preparation described above cleaved PtdEtn 
most rapidly, and lyso-PtdEtn slowly (Table 3). PtdOH hav-
ing OA did not serve as a substrate. PtdCho and other phos-
pholipids including Ptdlnt and PtdSer were practically inert. 
Among various FA moieties, OA was cleaved most rapidly, 
whereas AA and linoleic acid were released very slowly. The 
catalytic activity described above was slightly sensitive to BEL 
but not to AACOF3. 
4. Discussion 
The results presented above seem to indicate that HL-60 
cells contain a soluble Ca2+-insensitive PLA2 which releases 
unsaturated FAs, preferentially OA rather than AA, most 
rapidly from PtdEtn. Although it is premature to discuss 
the specificity of this enzyme, it also shows PLAi as well as 
lysophospholipase activity. PtdOH and PtdCho are very poor 
substrates. The iPLA2 recently cloned and identified from 
CHO cells and mouse macrophages by Tang et al. [8] and 
Balboa et al. [9] cleaves PtdOH and PtdCho rapidly in a 
mixed micelle assay. The CHO cell-derived PLA2 purified by 
Wolf and Gross [21] shows PLA2 as well as PLAi and lyso-
phospholipase activities in a vesicle assay. This enzyme cleaves 
AA from PtdCho, and interacts with ATP and calmodulin as 
was described for the 40 kDa iPLA2 from myocardium [22]. 
The enzyme described in this report shows properties that 
resemble those of PLAi purified partially from bovine brain 
cytosol by Pete et al. [23] which cleaves the acyl groups from 
the sn-l position of PtdEtn most rapidly and PtdCho and 
lysoPtdCho to some extent. PLAi purified from bovine testis 
by Higgs and Glomset [24] appears to react with PtdOH se-
lectively, but its recently described relation to human PtdOH-
specific secretory PLA2 [25] remains unknown, although both 
enzymes are postulated to play a role to generate a potent 
lipid mediator, lysoPtdOH. The apparent iPLA (A2/Ai) activ-
ity described in this report increases significantly during the 
differentiation of HL-60 cells to granulocytes. During HL-60 
cell differentiation by butyric acid a single lysophospholipase 
appears to be expressed [26]. The identity of this enzyme with 
that described herein is unclear. In short, numerous reports 
have recently appeared in the literature describing the exis-
tence of PLAi/PLA2 activities in the cytosol of mammalian 
tissues. The fatty acid preference and specificity of phospho-
lipid polar head groups appear to depend markedly on the 
assay conditions, particularly lipid compositions of the sub-
strate presented. Perhaps, sequence analysis is needed to dis-
cuss the identity or difference of various enzymes so far de-
scribed. 
Receptor-mediated activation of PLA2 was proposed first 
by Axelrod et al. [27]. cPLA2 has been well established to 
reveal its activity after phosphorylation by mitogen-activated 
protein kinase [5,6]. The C-terminal portion of cPLA2 is mul-
tiply phosphorylated by PKC [28]. The enzyme reported here 
appears to be responsible for the observation described earlier 
[11] that, with permeabilized HL-60 and U-937 cells, various 
FAs, particularly OA, are released in response to GTP-y-S, 
and that the release reaction is affected by ATP as well as the 
inhibitors of tyrosine kinase and PKC. It has been proposed 
that in guinea pig heart microsomes PtdEtn-hydrolyzing 
PLAi is directly activated by isoprenaline and guanine nucleo-
tides [29]. Nevertheless, no definitive evidence is yet available 
that any iPLA2 is coupled to receptor stimulation. Further 
exploration may provide the answer to the question whether 
the GTP-y-S-induced release of OA from the permeabilized 
Table 3 
Substrate specificity of PLA activity of peak II 
Substrate Fatty acid release (pmol) 
None 
Dioleoyl PtdEtn 
Dioleoyl PtdCho 
Dioleoyl POH 
Dioleoylglycerol 
Oleoyl-lysoPtdEtn 
Oleoyl-lysoPtdCho 
Oleoyl-lysoPOH 
Dilinoleoyl PtdEtn 
N.D. 
985 
71 
10 
N.D. 
248 
61 
N.D. 
142 
The enzymatic activity of partially purified peak II obtained from 
3-day differentiated HL-60 cell was determined in the presence of 
0.5 mM Mg2+ with various lipids (20 μΜ) as substrate. The reaction 
was carried out as described in Section 2. After incubation for 30 min, 
FA released was extracted and determined. 
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cells results from its direct coupling to receptors or from an 
indirect secondary effect from some perturbation of the cell 
membrane structure by other lipid messengers or mediators. 
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